Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate[1] Piperazine[1] D00807 --[1] 272
2(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate[1] Piperazine[1] D00807 --[1] 272
3Acido fusidico[1] Fusidic acid[1] D04281 --[1] 272
4ACIDO FUSIDICO/IDROCORTISONE ACETATO[1] Fusidic acid[1] D04281 --[1] 272
5AZD0530----[1] 272
6Garetosmab[1] Garetosmab[1] D11443 --[1] 272
7IDROCORTISONE ACETATO DYNACREN - 1 % CREMA 1 TUBO DA 30 G----[1] 272
8IDROCORTISONE ACETATO DYNACREN 1% CREMA----[1] 272
9INCB000928----[1] 272
10INCB000928 fumarate dihydrate----[1] 272
11IPN60120----[1] 272
12IPN60130----[1] 272
13IPN60130 10 mg capsules----[1] 272
14IPN60130 50 mg capsules----[1] 272
15Midazolam[1] Midazolam[1] D00550 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[12] 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
16PALOVAROTENE[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
17PALOVAROTENE - 1.5mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
18PALOVAROTENE - 10 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
19PALOVAROTENE - 1mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
20PALOVAROTENE - 2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
21PALOVAROTENE - 2.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
22PALOVAROTENE - 3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
23PALOVAROTENE - 4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
24PALOVAROTENE - 5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
25PALOVAROTENE 1.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
26Palovarotene dose level 1[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
27Palovarotene dose level 2[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
28Palovarotene dose level 3[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
29Palovarotene dose level 4[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
30PALOVAROTENE-2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
31PALOVAROTENE-3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
32PALOVAROTENE-4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
33Perhexiline[1] Perhexiline[1] D08340 [8] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬		[47] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 58, 272
34Piperazine[1] Piperazine[1] D00807 --[2] 58, 272
35REGN2477----[1] 272
36Saracatinib[1] Saracatinib[1] D09664 [2] ABL1,
SRC 💬		[49] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[3] 6, 89, 272
37SARACATINIB DIFUMARATE[1] Saracatinib[1] D09664 [2] ABL1,
SRC 💬		[49] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 272